Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 515 BS or Pravastatin in Hyperlipemic Healthy Male Subjects

NCT02266485 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BIBB 515 BS
DRUG: Pravastatin
DRUG: Placebo

Sponsor

Boehringer Ingelheim